NPCE
NeuroPace, Inc.
1W: +4.0%
1M: -7.2%
3M: -16.4%
YTD: -9.9%
1Y: +12.6%
3Y: +283.7%
$13.66
+0.13 (+0.96%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$0.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$459.9M
52W Range7.563-18.975
Volume169,283
Avg Volume213,569
Beta1.86
Dividend—
Analyst Ratings
Company Info
CEOJoel D. Becker
Employees184
SectorHealthcare
IndustryMedical - Devices
IPO Date2021-04-22
Websiteneuropace.com
455 North Bernardo Avenue
Mountain View, CA 94043
US
Mountain View, CA 94043
US
650 237 2700
About NeuroPace, Inc.
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
Latest News
12 Health Care Stocks Moving In Monday's Pre-Market Session
Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026
NPCE RNS System Explained: Growth Drivers and Setup for 2026
NeuroPace's Seizure ID and New Indication Could Expand RNS Demand
Analysts Set NeuroPace, Inc. (NASDAQ:NPCE) PT at $18.67
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Morrell Martha | F-InKind | 1,341 | $13.27 | 2026-03-24 |
| Geiger Uri | A-Award | 913 | $13.00 | 2026-03-20 |
| LACOB JOSEPH | A-Award | 865 | $13.00 | 2026-03-20 |
| Kumar Rakhi | A-Award | 1,153 | $13.00 | 2026-03-20 |
| Fischer Frank M | A-Award | 1,826 | $13.00 | 2026-03-20 |